Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Scinai Immunotherapeutics Ltd ADR (NQ: SCNI ) 5.310 -0.580 (-9.85%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Scinai Immunotherapeutics Ltd ADR < Previous 1 2 3 4 Next > 12 Health Care Stocks Moving In Monday's After-Market Session October 09, 2023 Via Benzinga Researchers Find Psoriasis Increases Risk of Heart Disease October 05, 2023 Via Investor Brand Network BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation at CPHI Barcelona 2023, Other Upcoming Events October 04, 2023 Via Investor Brand Network Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Secures $1.33 Million from Registered Direct Offering to Boost Commercial Development October 04, 2023 Via Investor Brand Network Why Food Allergy Prevalence Is Growing September 13, 2023 Via Investor Brand Network Scinai Immunotherapeutics to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI Barcelona 2023 October 04, 2023 Targeting biotech companies with drug production process development and optimization, analytical methods development, and GMP production for clinical trials From Scinai Immunotherapeutics Ltd. Via GlobeNewswire Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Finalizes Rebrand to Reflect New Strategic Direction, Diversification October 02, 2023 Via Investor Brand Network CDC Avails $262M to New Network Aimed at Responding to Future Disease Outbreaks September 29, 2023 Via Investor Brand Network Inverse Vaccines Show Promise Against Autoimmunity September 25, 2023 Via Investor Brand Network BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Closes on $1.33M Registered Direct Offering September 20, 2023 Via Investor Brand Network Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering September 19, 2023 From Scinai Immunotherapeutics Ltd. Via GlobeNewswire Study Shows Climate Change Impacts Infectious Disease Risks September 19, 2023 Via Investor Brand Network Topics Climate Change Exposures Climate Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session September 15, 2023 Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results. Via Benzinga BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces $1.33M Registered Direct September 15, 2023 Via Investor Brand Network Stocks That Hit 52-Week Lows On Friday September 15, 2023 Friday's session saw 169 companies set new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session September 15, 2023 Via Benzinga Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering September 15, 2023 From Scinai Immunotherapeutics Ltd. Via GlobeNewswire BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports on Plaque Psoriasis Treatment Study September 14, 2023 Via Investor Brand Network Exposures COVID-19 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 14, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session September 13, 2023 Via Benzinga Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results September 13, 2023 From Scinai Immunotherapeutics Ltd. Via GlobeNewswire Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) NanoAbs for Psoriasis Treatment May Offer Significant Advantages Over Apogee September 12, 2023 Via Investor Brand Network < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.